On October 13th, the 2023 CMC (Taizhou) Complex Formulation Industrialization Forum was successfully held at the Wanyi Hotel in Taizhou.
This forum was jointly organized by the Management Office of Taizhou Pharmaceutical High tech Zone Pharmaceutical Industry Park, the Party Committee of Taizhou Pharmaceutical High tech Zone (Gaogang District) Biopharmaceutical Industry Alliance, in collaboration with Aiweituo (Shanghai) Pharmaceutical Technology Co., Ltd., Suzhou Aitesen Pharmaceutical Equipment Co., Ltd., Zhuhai OMAX Instrument Co., Ltd., and Shanghai Fluke Technology Development Co., Ltd.
Experts from the upstream and downstream of the pharmaceutical industry gathered together to deeply share and exchange ideas on the research and production difficulties, industry status, and development prospects of new complex formulations.
Forum Background
With the exploration and discovery of new molecular solid drugs becoming increasingly difficult, the research and development of nucleic acid drugs is becoming increasingly popular, the cost of investment in new drug research and development is also increasing, the risks encountered are increasing, and market competition is also becoming increasingly fierce. Currently, drug research and development has entered an era of high-tech and high barrier drug formulation innovation. Whether it is the special formulation of small molecule drugs, the delivery carrier of nucleic acid drugs, or the development of composite adjuvants for new vaccines, the research of new complex formulations has clearly become one of the hotspots of drug innovation.
Opening Speech
At the beginning of the conference, Li Wei, Deputy Director of the Management Committee of China Pharmaceutical City in Taizhou, Jiangsu, delivered a speech.
Fuming Zhang
R&D Director of Boji Pharmaceutical Technology Co., Ltd
A Brief Discussion on the Factors Influencing the Industrialization of Lipid System Agents from the Perspective of Industry, University and Research
From early research and development to later commercial production, combined with years of experience in research and development, production line construction, and application in the field of complex injections, we comprehensively explored the different considerations in the research and development process of liposome formulations.
li Gan
General Manager of Fubicheng (Shanghai) Pharmaceutical Technology Co., Ltd
Developm...
(All Rights Reserved)